Lv73
4090 积分 2023-10-25 加入
Discovery of D6808, a Highly Selective and Potent Macrocyclic c-Met Inhibitor for Gastric Cancer Harboring MET Gene Alteration Treatment
4天前
已完结
Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities
1个月前
已完结
YCH1899, a Highly Effective Phthalazin-1(2H)-one Derivative That Overcomes Resistance to Prior PARP Inhibitors
1个月前
已完结
Discovery of dual PARP/NAMPT inhibitors for the treatment of BRCA wild-type triple-negative breast cancer
1个月前
已完结
Advances in Development of Selective Antitumor Inhibitors That Target PARP-1
2个月前
已完结
Development of Novel Phthalazinone-Triazole Hybrids as Potential Antidiabetic Agents Targeting GLUT4 Translocation in Skeletal Muscle
2个月前
已完结
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
2个月前
已完结
PARP and PARG inhibitors in cancer treatment
2个月前
已完结
An effective LC–MS method for the simultaneous determination of a potential anti‐rheumatoid arthritis drug, carboxyamidotriazole, and its major metabolite in rat plasma
2个月前
已完结
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
2个月前
已完结
皖公网安备34019202002308
